Crystalline and other solid form patents remain among the most valuable and most heavily litigated assets in pharmaceutical lifecycle management. In the past two years alone, at least 11 patent suits have been filed in the United States over crystalline form patents.
This webinar on Tuesday, December 8, at 12 PM ET, examines the latest Federal Circuit and district court decisions on how solid form claims are construed and tested, how claim scope is assessed under Section 112, and how novelty and obviousness are analyzed.
We will consider these issues through the lens of how solid form claims fit within a broader life sciences patent protection strategy. Throughout, we will offer practical guidance for drafting, prosecuting, and enforcing crystalline form claims, with particular attention to how solid-state data should be developed and presented.